Search Results
Feb 02, 2026, 09:04 ET Registration for SOHO 2026 is now open; Register by June 10, 2026 to receive early registration rates
a moment when research funding is in flux and cross-sector collaboration is more important than ever, according to SOHO President John DiPersio, MD, PhD."There has to be more of a collaborative effort between the public and private sectors to enhance these interactions so that we can continue to
More news about: Society of Hematologic Oncology
Feb 02, 2026, 08:52 ET Quest Diagnostics Launches Novel Flow Cytometry MRD Blood Test for Myeloma, Enabling Ultrasensitive Detection of Residual Disease
Cytometry MRD for Myeloma test made it clear to me that this assay has the potential to greatly improve the treatment paradigm," said Timothy Looney, PhD, Senior Director, Immuno-Oncology, Quest Diagnostics. "The sensitivity, cost, and sample stability that we can now offer to patients and their care team
More news about: Quest Diagnostics
Feb 02, 2026, 08:45 ET DEVONIAN APPOINTS DENNIS TURPIN AS CHIEF FINANCIAL OFFICER AND PROVIDES UPDATES ON STOCK OPTIONS GRANT
management approach, diversify our perspectives, enhance our collective expertise, and help guide the development of Devonian." said Dr. André P. Boulet, PhD, Chief Executive Officer. Mr. Turpin will replace Viktoria Krasteva, who will remain with the Company and assist ensuring a smooth transition
More news about: Devonian Health Group Inc.
Feb 02, 2026, 08:30 ET PhaseV Launches AI-Powered Enrollment Lab: Eliminating Guesswork and Grounding Study Design in Clinical Reality
Enrollment Lab, we are replacing theoretical planning with evidence-based certainty much earlier in the development lifecycle," said Raviv Pryluk, PhD, CEO and Co-founder of PhaseV. "By uncovering enrollment constraints and trade-offs, we enable sponsors to 'stress-test' their designs and ensure that
More news about: PhaseV
Feb 02, 2026, 07:43 ET IIM Udaipur Hosts D'Future - India Digital Conclave 2026, Spotlighting Technology-Led Growth, Resilience, and Inclusion
the importance of workforce adaptation and upskilling in an AI-driven future.The Indian research track was led by Probal Mojumder, Chairperson (PhD), IIM Udaipur. Prof. Mojumder spoke on building societal resilience through technology-enabled crisis response. Drawing on research conducted during
More news about: Indian Institute of Management Udaipur (IIMU)
Feb 01, 2026, 21:08 ET Organisasi Kanker Internasional Bekerja Sama Untuk Memenuhi Kebutuhan Pasien Kanker Wanita di Vietnam
tercanggih di seluruh dunia untuk menyediakan kualitas diagnosis dan pengobatan yang optimal bagi pasien kanker di Vietnam," kata Prof. Le Van Quang, MD, PhD, Direktur National Cancer Hospital dan Ketua NCCN Guidelines for Vietnam Panel for Ovarian Cancer. "Kerja sama dengan NCCN sangat penting. NCCN Guidelines
More news about: National Comprehensive Cancer Network
Jan 31, 2026, 03:15 ET Sanyou Bio's Decade: From an Intelligent Super-Trillion Antibody Library to the "Innovation Hub for Original Drug Discovery"
initial emergence and growth to fundamental transformation. In 2015, as regulatory reform ignited local innovation, Lang Guojun, after earning his PhD from Zhejiang University and gaining several years of experience in pharmaceutical companies, foresightedly focused on the core upstream segment of the
More news about: Sanyou Bio
Jan 30, 2026, 21:17 ET Apollo Neuroscience Announces 2025 Year in Review
David Rabin, MD, PhD, psychiatrist, translational neuroscientist, and co-founder of Apollo Neuroscience. "What we saw in 2025 was millions of people quietly improving
More news about: Apollo Neuroscience
Jan 30, 2026, 07:30 ET Solace Nutrition Announces Clinical and Scientific Updates for Encala®, the Original Structured-Lipid Medical Food for Fat Malabsorption
improvements in growth and nutritional status.The research was designed and conducted by David Yesair, PhD, inventor of the structured lipid compound; Walter Shaw, PhD, lipid biochemist responsible for manufacturing the original research-only formulation (Lym-X-Sorb®); and Dr. Stallings,
More news about: Solace Nutrition
Jan 30, 2026, 01:51 ET Aufsichtsgremien in Schwellenmärkten stehen laut globaler Studie von BCG, Heidrick & Struggles und INSEAD vor einer neuen Ära erhöhter Unsicherheit
Management, MBA, Global Executive MBA, spezialisierten Masterprogrammen (Executive Master in Finance und Executive Master in Change) sowie den PhD-Programmen. Darüber hinaus nehmen jedes Jahr mehr als 18 000 Führungskräfte an den Programmen der Führungskräfteweiterbildung (Executive Education) von INSEAD
More news about: Heidrick & Struggles
Jan 29, 2026, 19:30 ET School-Reported Reading Assessments Show Atypical Gains for Students With Dyslexia
The Morris Center. Founded by Dr. Tim Conway, PhD, a neuropsychology researcher, NOW! Programs® is grounded in neuroscience and a speech-to-print instructional framework that improves weaknesses in language
More news about: NOW! Programs®
Jan 29, 2026, 17:50 ET Poetiq Raises $45.8M for AI Meta-System, Surpasses Top LLMs on Industry Benchmark
problem and recursively improves the agent to become more accurate and cost-efficient.Poetiq was founded in June 2025 by co-CEOs Shumeet Baluja, PhD, and Ian Fischer, former AI researchers at Google DeepMind. Baluja was previously the CTO of Jamdat Mobile (IPO 2004) and spent the last 21 years with
More news about: Poetiq
Jan 29, 2026, 16:50 ET Boh Bah Inc. Bets Big on USA Manufacturing
popping boba brand in the United States.MANUFACTURING LEADERSHIPThe move leverages the experience of Managing Director, Benjamin Masters, PhD, who has led manufacturing companies in both USA and China for over 25 years.MANAGEMENT COMMENTARY"With tariffs and international logistics
More news about: Boba Vida
Jan 29, 2026, 16:50 ET Libris Innovations Welcomes Ramani Varanasi as Chief Executive Officer
and advisory services for emerging biotech ventures."Ramani's appointment marks an important step for Libris Innovations," said Alan Palkowitz, PhD, IBRI President and CEO. "Her leadership and experience will be instrumental in accelerating the translation of research into companies that deliver
More news about: Indiana Biosciences Research Institute
Jan 29, 2026, 16:46 ET Myosin Therapeutics Invited to Present at Biocom California's Global Partnering & Investor Conference
In addition to one-on-one partnering meetings and investor discussions, Courtney Miller, PhD, Chief Executive Officer, will present on the company's overall progress and future direction, with Karen Smith, MD, PhD, MBA, LLM, Chief Medical Officer, joining for investor and strategic partner engagements
More news about: Myosin Therapeutics Inc.
Jan 29, 2026, 15:21 ET Department of Education Proposed Rule Will Have Disastrous Impact on Nursing
care in their communities, not deter them from their career aspirations with an overly restrictive definition," said AANP President Valerie Fuller, PhD, DNP. "The proposed rule fundamentally misunderstands NP practice and discounts the skills and qualifications of NPs in communities across the country.
More news about: American Association of Nurse Practitioners (AANP)
Jan 29, 2026, 15:04 ET AllOne Health Research Finds EAP Counseling Resolves Most Employee Issues Within One Month Across Diverse Needs
engagement—particularly for complex, sensitive, or relationship-driven concerns. "The big story is the clinical diversity of EAP care" said Mark Attridge, PhD, the study's lead author. "We discovered a diverse profile of who the clients are, the kinds of organizations they work at, why they seek support and
More news about: AllOne Health
Jan 29, 2026, 11:35 ET TAM Global Study Challenges Stem Cell Claims for Wharton's Jelly Commercial Products
characterization, and validated clinical outcomes. With research operations in Boston, Nashville and Tijuana, TAM Global is a multidisciplinary team of 16 PhD scientists and 42 Medical doctors with a decade-long commitment to advancing regenerative medicine and cancer therapeutics. TAM Global is setting
More news about: The TAM Center
Jan 29, 2026, 11:15 ET PranaX Corporation Closes $17 million Oversubscribed Series A Round
fulfilling life."PranaX was founded on the belief that exosomes can redefine how we approach aging and long-term wellness," said Steven J. Greco, PhD, Founder and Chief Operating Officer of PranaX. "We are building a science-driven platform that bridges rigorous biological understanding with real-world
More news about: PranaX
Jan 29, 2026, 11:08 ET Innovative Labs Scales Health and Wellness Manufacturing with New High-Capacity Utah Facility
success in dynamic markets."Innovation and quality remain central to the company's approach. Innovative Labs' Innovation Center is staffed by PhD Steve Wood, alongside industry scientists who specialize in flavor science, advanced delivery systems, and market-driven formulation. The company also
More news about: Innovative Labs
Jan 29, 2026, 10:57 ET Renew Biotechnologies Advances Epigenetic Diagnostics Through Launch of Path Fertility's NOA Guide
processing.""For men with non-obstructive azoospermia, the decision to pursue surgical sperm retrieval can be daunting and deeply personal," said Kristin Brogaard, PhD, Co-founder & CSO, Path Fertility. "NOA Guide brings epigenetic insight earlier in the care journey, helping patients and clinicians approach these
More news about: Renew Biotechnologies
Jan 29, 2026, 10:23 ET Nucs AI Announces Medical Advisory Board to Accelerate Adoption of AI-Driven Theranostics
Jeremie Calais, MD, PhD, Medical Advisor — Director, Clinical Research Program of Nuclear Medicine and Theranostics at UCLA; Associate Professor, Ahmanson Translational Theranostics Division, Department of Nuclear Medicine and Theranostics A. Omer Nawaz, PhD, DABR, Independent Scientific
More news about: Nucs AI
Jan 29, 2026, 10:07 ET Avobis Bio Announces Expanded Primary Analysis Results from the Randomized Multicenter STOMP2 Clinical Trial to be Presented at European Crohn's and Colitis Organisation (ECCO) Congress
latest data with the U.S. Food and Drug Administration ("FDA") via a face-to-face meeting focused on expediting its development plan. Tiffany Brown, PhD, Chief Executive Officer of Avobis Bio stated "These latest trial results, along with FDA's recent in-person guidance, support our ongoing fundraising
More news about: Avobis Bio
Jan 29, 2026, 10:05 ET Prenosis Announces $20M BARDA Contract and $20M Series A Financing Round, Advancing Mission to Deliver Integrated Diagnostics and Therapeutics
including sepsis, pneumonia, acute heart failure (AHF), acute respiratory distress syndrome (ARDS), and acute kidney injury (AKI).Bobby Reddy, Jr., PhD, Prenosis CEO and co-founder explains, "Because of these investments, we are well-positioned to advance the development of biology-driven solutions that
More news about: Prenosis
Jan 29, 2026, 10:00 ET Great Minds and Renaissance Partner to Provide a Powerful Integration of Core Math Curriculum and Assessment Data
PhD Science®, and
More news about: Renaissance